Literature DB >> 9012236

[Femoropopliteal vascular replacement: vein, ePTFE or ovine collagen?].

G Koch1, S Gutschi, O Pascher, J Fruhwirth, H Hauser.   

Abstract

In an eight year-period from 1988 to 1995 653 femoropopliteal and femorocrural bypasses were performed. 347 above-knee reconstructions 206 below-knee reconstructions and at last 100 femorocrural bypasses were analysed. The cumulative patency rate after a follow up of three years for above-knee vein bypasses was 90%, patency rate for PTFE grafts in the same period was 52%, for ovine collagen grafts 56%. For below-knee bypasses with autologous saphenous vein a function rate of 76% could be observed in the same period, the rate of PTFE grafts in this position was only 30%. In this position 3-year patency rates of 50% were achieved with ovine collagen grafts. This difference was statistically significant. Three years cumulative patency rate for femorocrural reconstructions with greater saphenous vein was 72%, the function rate for PTFE in this position was below 30% after a follow up of one year, with ovine grafts below 40%. Graft infection, aneurysm formation and postoperative mortality were low in all groups. Our data demonstrate, that patency rates of autologous vein bypasses could not be achieved with PTFE or ovine collagen prosthesis in any femoropopliteal the femorocrural position. We therefore cannot confirm the recommendation to use alloplastic grafts as primary choice for above knee bypasses to spare the saphenous vein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9012236

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  3 in total

1.  Which prosthesis is more resistant to vascular graft infection: polytetrafluoroethylene or Omniflow II biosynthetic grafts?

Authors:  Orhan Bozoglan; Bulent Mese; Erdinc Eroglu; Serdal Elveren; Mustafa Gul; Ahmet Celik; Halil Ibrahim Yildirimdemir; Harun Ciralik; Alptekin Yasim
Journal:  Surg Today       Date:  2015-03-06       Impact factor: 2.549

2.  Long-term outcomes of Omniflow II biosynthetic vascular graft in lower extremity arterial revascularization.

Authors:  Faruk Toktaş; Mustafa Çağdaş Çayır; Kadir Kaan Özsin; Şenol Yavuz; Mehmet Tuğrul Göncü
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-07-03       Impact factor: 0.332

Review 3.  Clinical results of biologic prosthesis: A systematic review and meta-analysis of comparative studies.

Authors:  Chumpon Wilasrusmee; Boonying Siribumrungwong; Suthas Horsirimanont; Napaphat Poprom; Jakrapan Jirasiritham; Ammarin Thakkinstian
Journal:  Ann Med Surg (Lond)       Date:  2017-01-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.